Relay Therapeutics, Inc. (RLAY)
Data as of , from SEC Form 4 filings.
See up to 3 months of RLAY. The 7-day demo opens the 1M and 3M ranges and puts RLAY on your watchlist.
Start 7-day demoLatest RLAY insider trades
About Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. is an SEC registrant, filing under CIK 0001812364, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
RLAY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 6,215,260 | $120.52M |
RLAY insider transactions (Form 4)
1067 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 3 of 3.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas Catinazzo - Officer | Open-market sale | Common Stock | 1,697 | $6.06 | $10K | |
| Thomas Catinazzo - Officer | Open-market sale | Common Stock | 5,105 | $6.06 | $31K | |
| Thomas Catinazzo - Officer | Open-market sale | Common Stock | 2,300 | $5.95 | $14K | |
| Donald A. Bergstrom - Officer | Open-market sale | Common Stock | 2,688 | $6.06 | $16K | |
| Brian Adams - Officer | Open-market sale | Common Stock | 1,632 | $6.06 | $10K | |
| Peter Rahmer - Officer | Open-market sale | Common Stock | 245 | $7.51 | $2K | |
| Thomas Catinazzo - Officer | Open-market sale | Common Stock | 295 | $7.51 | $2K | |
| Thomas Catinazzo - Officer | Open-market sale | Common Stock | 6,162 | $7.46 | $46K | |
| Donald A. Bergstrom - Officer | Open-market sale | Common Stock | 648 | $7.51 | $5K | |
| Brian Adams - Officer | Open-market sale | Common Stock | 295 | $7.51 | $2K |
Recent RLAY Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Sanjiv Patel | Director, Officer | 96,401 | $1.81M | View on EDGAR | |
| Thomas Catinazzo | Officer | 93,153 |
RLAY insider trading FAQ
What is the latest insider trade for RLAY?
Relay Therapeutics, Inc. (RLAY) had 12 insider filings in the last 90 days, with the most recent on 30 October 2026. The full record for RLAY runs to 67 Form 4 filings, the earliest from 1 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RLAY stock?
No insider purchases of RLAY were filed in the last 90 days.
How many insiders are selling RLAY stock?
13 insider sales of RLAY were filed in the last 90 days, totaling $120.52M.
Where can I see RLAY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RLAY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Peter Rahmer view on EDGAR
- - Donald A. Bergstrom view on EDGAR
- - Thomas Catinazzo view on EDGAR
- - Sanjiv Patel view on EDGAR
- - Thomas Catinazzo view on EDGAR
- - Donald A. Bergstrom view on EDGAR
- - Thomas Catinazzo view on EDGAR
- - Sanjiv Patel view on EDGAR
- - Peter Rahmer view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where RLAY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RLAY with a 7-day demo
- RLAY on your watchlist
- Every RLAY Form 4 filing on record
- Up to 3 months of RLAY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
